Details der Publikation - Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study

Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study

Abstract Coronavirus disease 2019 (COVID-19) represents a major health problem in terms of deaths and long-term sequelae. We conducted a retrospective cohort study at Montichiari Hospital (Brescia, Italy) to better understand the determinants of outcome in two different COVID-19 outbreaks. A total of 634 unvaccinated patients admitted from local emergency room to the Internal Medicine ward with a confirmed diagnosis of SARS-CoV-2 infection and a moderate-to-severe COVID-19 were included in the study. A group of 260 consecutive patients during SARS-CoV-2 first wave (from February to May 2020) and 374 consecutive patients during SARS-CoV-2 2nd/3rd wave (from October 2020 to May 2021) were considered. Demographic data were not significantly different between waves, except a lower prevalence of female sex during first wave. Mortality was significantly higher during the $ 1^{st} $ wave than in the following periods (24.2% vs. 11%; p < 0.001). Time from symptoms onset to hospital admission was longer during first wave (8 ± 6 vs. 6 ± 4 days; p < 0.001), while in-hospital staying was significantly shorter (10 ± 14 vs. 15 ± 11 days; p < 0.001). Other significant differences were a larger use of corticosteroids and low-molecular weight heparin as well less antibiotic prescription during the second wave. Respiratory, bio-humoral and X-ray scores were significantly poorer at the time of admission in first-wave patients. After a multivariate regression analysis, C-reactive protein and procalcitonin values, % fraction of inspired oxygen on admission to the Internal Medicine ward and length of hospital stay and duration of symptoms were the strongest predictors of outcome. Concomitant anti-hypertensive treatment (including ACE-inhibitors and angiotensin-receptor blockers) did not affect the outcome. In conclusion, our data suggest that earlier diagnosis, timely hospital admission and rational use of the therapeutic options reduced the systemic inflammatory response and were associated to a better outcome during the 2nd/3rd wave..

Medienart:	E-Artikel

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	Zur Gesamtaufnahme - volume:17
Enthalten in:	Internal and emergency medicine - 17(2022), 7 vom: 09. Juli, Seite 1941-1949

Sprache:	Englisch

Beteiligte Personen:	Leidi, Francesca [VerfasserIn] Boari, Gianluca Edoardo Mario [VerfasserIn] Scarano, Ottavio [VerfasserIn] Mangili, Benedetta [VerfasserIn] Gorla, Giulia [VerfasserIn] Corbani, Andrea [VerfasserIn] Accordini, Beatrice [VerfasserIn] Napoli, Federico [VerfasserIn] Ghidelli, Chiara [VerfasserIn] Archenti, Giulia [VerfasserIn] Turini, Daniele [VerfasserIn] Saottini, Michele [VerfasserIn] Guarinoni, Vittoria [VerfasserIn] Ferrari-Toninelli, Giulia [VerfasserIn] Manzoni, Francesca [VerfasserIn] Bonetti, Silvia [VerfasserIn] Chiarini, Giulia [VerfasserIn] Malerba, Paolo [VerfasserIn] Braglia-Orlandini, Federico [VerfasserIn] Bianco, Gianluca [VerfasserIn] Faustini, Cristina [VerfasserIn] Agabiti-Rosei, Claudia [VerfasserIn] De Ciuceis, Carolina [VerfasserIn] Rizzoni, Damiano [VerfasserIn]

Links:	Volltext [kostenfrei]

BKL:	44.80$jUnfallmedizin$jNotfallmedizin
Themen:	COVID-19 Mortality Prognostic factors SARS-CoV2 Waves

Anmerkungen:	© The Author(s) 2022

doi:	10.1007/s11739-022-03034-5

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2132220697

Internformat


LEADER	01000naa a22002652 4500
001	OLC2132220697
003	DE-627
005	20230506071947.0
007	cr uuu---uuuuu
008	230506s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s11739-022-03034-5 \|2 doi
035			\|a (DE-627)OLC2132220697
035			\|a (DE-He213)s11739-022-03034-5-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a 44.80$jUnfallmedizin$jNotfallmedizin \|2 bkl
100	1		\|a Leidi, Francesca \|e verfasserin \|4 aut
245	1	0	\|a Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © The Author(s) 2022
520			\|a Abstract Coronavirus disease 2019 (COVID-19) represents a major health problem in terms of deaths and long-term sequelae. We conducted a retrospective cohort study at Montichiari Hospital (Brescia, Italy) to better understand the determinants of outcome in two different COVID-19 outbreaks. A total of 634 unvaccinated patients admitted from local emergency room to the Internal Medicine ward with a confirmed diagnosis of SARS-CoV-2 infection and a moderate-to-severe COVID-19 were included in the study. A group of 260 consecutive patients during SARS-CoV-2 first wave (from February to May 2020) and 374 consecutive patients during SARS-CoV-2 2nd/3rd wave (from October 2020 to May 2021) were considered. Demographic data were not significantly different between waves, except a lower prevalence of female sex during first wave. Mortality was significantly higher during the $ 1^{st} $ wave than in the following periods (24.2% vs. 11%; p < 0.001). Time from symptoms onset to hospital admission was longer during first wave (8 ± 6 vs. 6 ± 4 days; p < 0.001), while in-hospital staying was significantly shorter (10 ± 14 vs. 15 ± 11 days; p < 0.001). Other significant differences were a larger use of corticosteroids and low-molecular weight heparin as well less antibiotic prescription during the second wave. Respiratory, bio-humoral and X-ray scores were significantly poorer at the time of admission in first-wave patients. After a multivariate regression analysis, C-reactive protein and procalcitonin values, % fraction of inspired oxygen on admission to the Internal Medicine ward and length of hospital stay and duration of symptoms were the strongest predictors of outcome. Concomitant anti-hypertensive treatment (including ACE-inhibitors and angiotensin-receptor blockers) did not affect the outcome. In conclusion, our data suggest that earlier diagnosis, timely hospital admission and rational use of the therapeutic options reduced the systemic inflammatory response and were associated to a better outcome during the 2nd/3rd wave.
650		4	\|a COVID-19
650		4	\|a SARS-CoV2
650		4	\|a Prognostic factors
650		4	\|a Waves
650		4	\|a Mortality
700	1		\|a Boari, Gianluca Edoardo Mario \|4 aut
700	1		\|a Scarano, Ottavio \|4 aut
700	1		\|a Mangili, Benedetta \|4 aut
700	1		\|a Gorla, Giulia \|4 aut
700	1		\|a Corbani, Andrea \|4 aut
700	1		\|a Accordini, Beatrice \|4 aut
700	1		\|a Napoli, Federico \|4 aut
700	1		\|a Ghidelli, Chiara \|4 aut
700	1		\|a Archenti, Giulia \|4 aut
700	1		\|a Turini, Daniele \|4 aut
700	1		\|a Saottini, Michele \|4 aut
700	1		\|a Guarinoni, Vittoria \|4 aut
700	1		\|a Ferrari-Toninelli, Giulia \|4 aut
700	1		\|a Manzoni, Francesca \|4 aut
700	1		\|a Bonetti, Silvia \|4 aut
700	1		\|a Chiarini, Giulia \|4 aut
700	1		\|a Malerba, Paolo \|4 aut
700	1		\|a Braglia-Orlandini, Federico \|4 aut
700	1		\|a Bianco, Gianluca \|4 aut
700	1		\|a Faustini, Cristina \|4 aut
700	1		\|a Agabiti-Rosei, Claudia \|4 aut
700	1		\|a De Ciuceis, Carolina \|4 aut
700	1		\|a Rizzoni, Damiano \|0 (orcid)0000-0002-1253-0186 \|4 aut
773	0	8	\|i Enthalten in \|t Internal and emergency medicine \|d Springer International Publishing, 2006 \|g 17(2022), 7 vom: 09. Juli, Seite 1941-1949 \|h Online-Ressource \|w (DE-627)538216425 \|w (DE-600)2378342-4 \|w (DE-576)275077535 \|x 1970-9366 \|7 nnns
773	1	8	\|g volume:17 \|g year:2022 \|g number:7 \|g day:09 \|g month:07 \|g pages:1941-1949
856	4	0	\|u https://dx.doi.org/10.1007/s11739-022-03034-5 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2132
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	b	k	\|a 44.80$jUnfallmedizin$jNotfallmedizin \|q VZ \|0 106409794 \|0 (DE-625)106409794
951			\|a AR
952			\|d 17 \|j 2022 \|e 7 \|b 09 \|c 07 \|h 1941-1949

Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände